hnRNPM, a potential mediator of YY1 in promoting the epithelial-mesenchymal transition of prostate cancer cells.

Abstract

BACKGROUND:

With the popularity of serum prostate-specific antigen (PSA) screening, the number of newly diagnosed prostate cancer (PCa) patients is increasing. However, indolent or invasive PCa cannot be distinguished by PSA levels. Here, we mainly explored the role of heterogeneous nuclear ribonucleoprotein M (hnRNPM) in the invasiveness of PCa.

METHODS:

Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and Western blot analysis was used to detect the expressions of hnRNPM in PCa and benign prostate hyperplasia (BPH) tissues as well as in PCa cell lines. Immunohistochemistry was applied to detect the hnRNPM or Yin Yang 1 (YY1) expression in BPH, prostate adenocarcinoma (ADENO) and neuroendocrine prostate cancer (NEPC) tissues. After aberrant, the expression of hnRNPM in C4-2 and PC3 cells, the changes of cell migration and invasion were observed through wound-healing and transwell assays. We also predicted the transcription factor of hnRNPM through databases, then verified the association of hnRNPM and YY1 using chromatin immunoprecipitation (ChIP) and luciferase assays.

RESULTS:

The expression level of hnRNPM is gradually reduced in BPH, ADENO, and NEPC tissues and it is less expressed in more aggressive PCa cell lines. Overexpression of hnRNPM can significantly reduce Twist1 expression, which inhibits the migration and invasion of PCa cells in vitro. In PCa cells, overexpression of YY1 can promote epithelial-mesenchymal transition by reducing hnRNPM expression. Furthermore, this effect caused by overexpression of YY1 can be partially attenuated by simultaneous overexpression of hnRNPM.

CONCLUSIONS:

Our study demonstrates that hnRNPM negatively regulated PCa cell migration and invasion, and its expression can be transcriptionally inhibited by YY1. We speculated that hnRNPM may be a biomarker to assist in judging the aggressiveness of PCa.

• Authors: Tong Yang, Zesheng An, Changwen Zhang, Zhen Wang, Xiaoming Wang, Yan Liu, E Du, Ranlu Liu, Zhihong Zhang, Yong Xu
• Journal: The Prostate (Prostate) Vol. 79 Issue 11 Pg. 1199-1210 (08 2019) ISSN: 1097-0045 [Electronic] United States
• PMID: 31251827 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: © 2019 Wiley Periodicals, Inc.

Chemical References

• Heterogeneous-Nuclear Ribonucleoprotein Group M
• YY1 Transcription Factor
• YY1 protein, human

Topics

• Adenocarcinoma (genetics, metabolism, pathology)
• Cell Line, Tumor
• Cell Movement (physiology)
• Epithelial-Mesenchymal Transition (physiology)
• Gene Expression Regulation, Neoplastic
• Heterogeneous-Nuclear Ribonucleoprotein Group M (genetics, metabolism)
• Humans
• Male
• Neoplasm Invasiveness (genetics, pathology)
• Prostatic Hyperplasia (genetics, metabolism, pathology)
• Prostatic Neoplasms (genetics, metabolism, pathology)
• YY1 Transcription Factor (genetics, metabolism)